Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (50)

2024

  1. Respiratory syncytial virus: A new era

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 134-148

2023

  1. Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 466-469

  2. Tuberculosis in Spain: An opinion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 562-583

2022

  1. Actions and attitudes on the immunized patients against SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 7-15

  2. COVID in Pediatric Age: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 333-343

  3. COVID-19: Some unresolved issues

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 421-434

  4. Comparison of the Performance of Two Galactomannan Detection Tests: Platelia Aspergillus Ag and Aspergillus Galactomannan Ag Virclia Monotest

    Microbiology spectrum, Vol. 10, Núm. 2, pp. e0262621

  5. Lessons from COVID-19 for future disasters: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 444-454

  6. Monkeypox in humans: a new outbreak

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 6, pp. 509-518

  7. Persistence and viability of SARS-CoV-2 in primary infection and reinfections

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 1-6

2021

  1. New variants of SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 5, pp. 419-428

  2. Post-covid syndrome: A reflection and opinion paper

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 4, pp. 269-279

2020

  1. Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: A multidisciplinary opinion document

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 1, pp. 49-67

2019

  1. Is it reasonable to perform fecal microbiota transplantation for recurrent clostridium difficile infection in patients with liver cirrhosis?

    Revista Espanola de Quimioterapia

2018

  1. A young patient with fever after heart transplantation

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 5, pp. 443-451

  2. Can dalbavancin be used as a catheter lock solution?

    Journal of Medical Microbiology, Vol. 67, Núm. 7, pp. 936-944

  3. Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC)

    Medicina Intensiva, Vol. 42, Núm. 1, pp. 5-36

  4. Executive summary: Diagnosis and Treatment of Catheter-Related Bloodstream Infection: Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 2, pp. 112-119

2015

  1. Nationwide study on the use of intravascular catheters in internal medicine departments

    Journal of Hospital Infection, Vol. 90, Núm. 2, pp. 135-141

2014

  1. European society of clinical microbiology and infectious diseases: Update of the treatment guidance document for Clostridium difficile infection

    Clinical Microbiology and Infection, Vol. 20, Núm. S2, pp. 1-26